New TB vaccine put to the test with aerosol exposure
NCT ID NCT06670755
First seen Nov 18, 2025 · Last updated May 11, 2026 · Updated 23 times
Summary
This study tests the safety of a new tuberculosis (TB) vaccine called ID93/GLA-SE. Forty-eight healthy adults, some previously vaccinated with BCG and some not, will receive the new vaccine and then be exposed to a harmless form of TB bacteria through an aerosol mist. Researchers will monitor for side effects and measure immune responses to see how well the vaccine works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre for Clinical Vaccinology and Tropical Medicine
Oxford, Oxfordshire, OX3 7LE, United Kingdom
Conditions
Explore the condition pages connected to this study.